Albumin is the most abundant protein in the circulation. Its main physiologic function is to maintain colloid osmotic pressure. Better understanding of albumin's other physiologic functions has ...

Zydus Lifesciences subsidiary has partnered with Zhuhai Beihai Biotech to market a cancer drug, Beizray (Albumin Solubilized ...

Aptamers are single-stranded DNA or RNA molecules with unique 3D structures that allow for specific binding to a wide variety of ions and molecules. Due to their unique properties, aptamers have been ...

Ahmedabad: Zydus Lifesciences Ltd., a global healthcare company has announced that its wholly owned subsidiary, Zydus ...

EP3583125 B1 for Fully Human Albumin Binding (FHAB®) domain fusion ... Sonnet's FHAB platform enables rapid development of targeted biologic drugs, with ongoing clinical programs aimed at ...

Detailed price information for Sonnet Biotherapeutics Holdings Inc (SONN-Q) from The Globe and Mail including charting and trades.

Sonnet BioTherapeutics has received a patent from the European Patent Office (EPO) for its fully human albumin binding (F H ...

New Delhi: A team of Japanese researchers has found a class of diabetes drugs that help the kidneys ... which enables albumin -- a type of protein -- to pass through these filters and end up ...